| BDAIX | GFACX | BDAIX / GFACX | |
| Total Expense Ratio | 0.70 | 1.36 | 51% |
| Annual Report Gross Expense Ratio | 0.77 | 1.36 | 57% |
| Fund Existence | 8 years | 25 years | - |
| Gain YTD | 15.678 | 19.322 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 525M | 339B | 0% |
| Annual Yield % from dividends | 0.20 | 0.00 | - |
| Returns for 1 year | 14.14 | 5.80 | 244% |
| Returns for 3 years | 101.54 | 56.29 | 180% |
| Returns for 5 years | 114.79 | 23.23 | 494% |
| Returns for 10 years | N/A | 76.11 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ADVE | 39.16 | 0.09 | +0.23% |
| Matthews Asia Dividend Active ETF | |||
| PFFA | 21.45 | 0.03 | +0.16% |
| Virtus InfraCap US Preferred Stock ETF | |||
| XFIV | 49.65 | 0.04 | +0.08% |
| BondBloxx Bloomberg FiveYrTrgDurUSTrsETF | |||
| RDTL | 48.21 | -0.20 | -0.41% |
| GraniteShares 2x Long RDDT Daily ETF | |||
| BIB | 78.92 | -0.98 | -1.22% |
| ProShares Ultra Nasdaq Biotechnology | |||